Björnsson E, Jørgensen K, Rossi M. "Method for the Synthesis of 2-(5-Methyl-1,2,4-oxadiazol-3-yl)ethanamine;hydrochloride" [P]. European Patent, EP 3463759 A1, 2020-08-04.
Stevens L M, Davis P L, Roberts E F. "A Process for Preparing High-Purity 2-(5-Methyl-1,2,4-oxadiazol-3-yl)ethanamine;hydrochloride" [P]. US Patent, US 9164777 B2, 2022-01-27.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2012, 2425, (2), 5439-5468.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2020, 320, (8), 1902-1914.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 2-(5-Methyl-1,2,4-oxadiazol-3-yl)ethanamine;hydrochloride Using HRMS and NMR". Molecules, 2012, 843, (4), 6186-6195.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2022, 2348, 8626-8652.